These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8236147)

  • 1. Standards for assay of von Willebrand factor concentrates: a collaborative study.
    Fricke WA; Lamb MA; Rastogi SC
    Thromb Haemost; 1993 Aug; 70(2):351-6. PubMed ID: 8236147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardisation of factor VIII--V. Calibration of the 2nd International Standard for Factor VIII and von Willebrand factor activities in plasma.
    Heath AB; Barrowcliffe TW
    Thromb Haemost; 1992 Aug; 68(2):155-9. PubMed ID: 1412160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
    Neugebauer BM; Goy C; Budek I; Seitz R
    Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
    Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative in vitro evaluation of six von Willebrand factor concentrates.
    Lethagen S; Carlson M; Hillarp A
    Haemophilia; 2004 May; 10(3):243-9. PubMed ID: 15086321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. von Willebrand factor standards for plasma and concentrate testing.
    Hubbard AR
    Semin Thromb Hemost; 2006 Jul; 32(5):522-8. PubMed ID: 16862526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Willebrand factor/factor VIII concentrates in the treatment of von Willebrand disease.
    Batlle J; López-Fernández MF; Fraga EL; Trillo AR; Pérez-Rodríguez MA
    Blood Coagul Fibrinolysis; 2009 Mar; 20(2):89-100. PubMed ID: 19786936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
    Budde U; Metzner HJ; Müller HG
    Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new automated screening assay for the diagnosis of von Willebrand disease.
    Salem RO; Van Cott EM
    Am J Clin Pathol; 2007 May; 127(5):730-5. PubMed ID: 17439831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification and facilitated comparison of von Willebrand factor multimer patterns by densitometry.
    Studt JD; Budde U; Schneppenheim R; Eisert R; von Depka Prondzinski M; Ganser A; Barthels M
    Am J Clin Pathol; 2001 Oct; 116(4):567-74. PubMed ID: 11601142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test.
    Mori F; Rossi P; Nardini I; Gambelli D; Farina C
    Blood Coagul Fibrinolysis; 2010 Apr; 21(3):221-8. PubMed ID: 20179578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological activity of von Willebrand factor during the manufacture of therapeutic factor VIII concentrates as determined by the collagen-binding assay.
    Ramasamy I; Farrugia A; Tran E; Anastasius V; Charnock A
    Biologicals; 1998 Jun; 26(2):155-66. PubMed ID: 9811523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of von Willebrand disease type 2N (Normandy) in Australia: a cross-laboratory investigation using different methods.
    Rodgers SE; Lerda NV; Favaloro EJ; Duncan EM; Casey GJ; Quinn DM; Hertzberg M; Lloyd JV
    Am J Clin Pathol; 2002 Aug; 118(2):269-76. PubMed ID: 12162689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
    Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
    Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
    Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
    Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to think outside the box? Proposals for a new approach to future pharmacokinetic studies of von Willebrand factor concentrates in people with von Willebrand disease.
    Favaloro EJ; Kershaw G; McLachlan AJ; Lloyd J
    Semin Thromb Hemost; 2007 Nov; 33(8):745-58. PubMed ID: 18175280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.